20 July 21 July 22 July 23 July


Simposia 20 July




20 July

10:30

SY01

Toxicosurveillance- Current status and future prospects
Nickholas Bateman. University of Edinburgh. GBR

 

 

SY01-1

Toxicosurveillance Spanish Program
Ana Ferrer-Dufol. Unit of Clinical Toxicology. Clinical Hospital. Zaragoza. ESP

 

 

SY01-2

Practical approaches to toxicosurveillance in Asia.
Andrew Dawson. Faculty of Medicine, University of Peradeniya . Peradeniya.. SRI

 

 

SY01-3

Using epidemiological data to study lethal occupational exposures
David Coggon. MRC. Epidemiology Resource Centre, University of Southampton. GBR

 

 

SY01-4

Toxicosurveillance using poison center data-streams
Salome Ballesteros. Servicio Informacion Toxicológica. Madrid

 

 

SY01-5

International collaboration in Toxicosurveillance: a WHO perspective
Tim J Meredith. International Programme on Chemical Safety. World Health Organization. Geneva.CHE


20 July

10:30

SY02

Sensory Systems as Toxicity Targets
Larry Fechter. Jerry Pettis Memorial Veterans Medical Center. USA

 

 

SY02-1

Can the synergistic effects of a combined exposure to noise and solvents be explained through the pharmacological effects of solvents on the central nervous system?
Pierre Campo, Institut National de Recherche et de Sécurité. FR

 

 

SY02-2

Toxicity of Nitriles on the Peripheral Vestibular System: Defining New Families of Compounds with “Classic-Type” of Inner Ear Toxicity.
Jordi Llorens
. Universitat de Barcelona. ESP

 

 

SY02-3

Visual Effects of Exposure to Volatile Organic Solvents in an Animal Model
William K. Boyes, US Environmental Protection Agency. USA

 

 

SY02-4

Chemosensory Effects of Exposure to Volatile Organic Compounds in Humans
Christoph van Thriel
. Leibniz Research Centre for Working Environment and Human Factors at the University of Dortmund. DEU

 

 

SY02-5

Chemical exposure as a risk factor for hearing loss: implications for occupational health
Ann-Christin Johnson
.Karolinska Institute. SWE


20 July

10:30

SY03

Safe Nanotechnologies - A Challenge for the Future
Kai Savolainen. Finnish Institute of Occupational Health, Helsinki. FIN

 

 

SY03-1

New Lessons of Safety Challenges of Engineered Nanoparticles - Introduction
Kai Savolainen. Finnish Institute of Occupational Health, Helsinki. FIN

 

 

SY03-2

Causality of Exposure to Engineered Nanoparticles and Their Biological Effects
Allison Elder. School of Medicine & Dentistry, University of Rochester, Rochester, NY, USA. USA

 

 

SY03-3

Nanotoxicology: Biological effects of manufactured nanoparticles and their health
Yuliang Zhao. Institute of High Energy Physcs. Chinese Academy of Science Beijing. CHN

 

 

SY03-4

Assessment of Exposure to Nanoparticles in Occupational Setting
Gerhard Kasper. Institut für Mechanische Verfahrenstechnik und Mechanik. University of Karlsruhe. DEU

 

 

SY03-5

Carbon Nanotubes - Challenges for Assuring Safety of Nanotechnologies
Ken Donaldson. MRC Centre for Inflammation Research (CIR). University of Edinburgh. GBR


20 July

10:30

SY04

The diet in colon cancer development
Dieter Schrenk; Pablo Steinberg
. Universitat. Kaiserslautern.  University of Veterinary Medicine Hannover. DEU

 

 

SY04-1

In vitro models to study diet-related colon cancer induction and prevention
Jenifer I. Fenton
. Department of Food Science and Human Nutrition, Michigan State University. USA

 

 

SY04-2

Red and processed meat intake and risk of colorectal adenoma and carcinoma from a molecular epidemiological point of view
Rashmi Sinha
. Division of Cancer Epidemiology and Genetics, National Cancer Institute. USA

 

 

SY04-3

The role of folate in colon cancer development
Robert Clarke
. Clinical Trial Service Unit, University of Oxford. GBR

   

SY04-4

The role of flat dysplastic aberrant crypt foci induced in the colon by food contaminants
Jan Alexander
. Division of Environmental Medicine, Norwegian Institute of Public Health. NOR
   

SY04-5

The role of inflammation in colon cancer induced by food contaminants
Pablo Steinberg
. Institute for Food Toxicology and Analytical Chemistry University of Veterinary Medicine Hannover. DEU



20 July

16:30

SY05

Biomarkers and Molecular Mechanisms in Pesticide Toxicity
Arturo Anadón. . Complutense University. Madrid. SP

 

 

SY05-1

In Vivo Biomarkers of Neurotoxicity Induced by Organophosphates and Carbamates
Ramesh C. Gupta. Murray State University. USA

 

 

SY05-2

Plasma ß-glucuronidase as an alternative biomarker to cholinesterase for organophosphate exposure
Tetsuo Satoh. Chiba University. JPN

 

 

SY05-3

Application of biomarkers of exposure, effect and susceptibility to subjects long-term exposed to pesticides
Antonio F. Hernández. University of Granada School of Medicine. Granada. ESP

 

 

SY05-4

Effects of organophosphate exposure on male reproductive outcomes
B. Quintanilla-Vega. Departamento  de Toxicología, CINVESTAV, Zacatenco, Mexico DF. MEX


20 July

16:30

SY06

Effects of climate change on human health - special focus on contaminants.
Arja Rautio
. University of Oulu,. FIN

 

 

SY06-1

Climate change, contaminant and Alaska native health
James E. Berner. Alaska Native Tribal Health Consortium, Anchorage, Alaska. USA

 

 

SY06-2

Human health in the context of changing ecosystems and environment
Arja Rautio. University of Oulu,. FIN

 

 

SY06-3

The North - South dimension –are the effects of climate change equal in the South and North?
Jon Oyving Odland. University of Tromso. NOR

 

 

SY06-4

Climate change, contaminants and human health in Arctic Russia.
Valery P. Chaschin. Mechnikov Medical Academy, Moscow. RUS

   

SY06-5

The environmental health and contaminants in South Africa
Halina. B. Röllin. South African Medical Research Council (abstract in P308-047)

20 July

16:30

SY07

New Developments in Pulmonary Carcinogenesis
Heidi Foth. University of Halle, Germany (President of the German Society of Toxicology (GT). DEU

 

 

SY07-1

Deregulated EGFR Signaling during Lung Cancer Progression
Adi Gazdar. University of Texas Southwestern Medical Center, Dallas. USA

 

 

SY07-2

Pattern of in  vitro stress response of lung cells from lung cancer cases
Heidi Foth. University of Halle, Germany (President of the German Society of Toxicology (GT). DEU

 

 

SY07-3

Transgenic and Smoke-Induced Rodent Lung Cancer Models
Hans-Juergen Haussmann. Toxicology Consultant, Roesrath. DEU

 

 

SY07-4

Changes of the genome DNA methylation in the progress of benzo[a]pyrene-induced transformation
Zhixiong Zhuang. ShenZhen Center for Disease Control and Prevention. CHI (Short communication) (abstract in P203-030)


20 July

17:00

SY08

Genetic polymorphism and drug metabolizing enzymes
Edmund Maser
. Institute of Toxicology and Pharmacology, Univ. Med. School Schleswig-Holstein, Kiel. DEU

 

 

SY08-2

Carbonyl  Reductases/Steroid  Dehydrogenases:  Biology,  Classification  and  Implication  in  Drug  Metabolism  and  Detoxification
Edmund Maser
. Institute of Toxicology and Pharmacology, Univ. Med. Sch. Schleswig-Holstein, Kiel. DEU

 

 

SY08-3

Metabolic activation of PAHs by aldo-keto reductases
Trevor M. Penning
. Philadelphia,. USA

 

 

SY08-4

Epoxide hydrolases: structure, function, mechanism and toxicological implication
Michael Arand
. Zurich. CHE

 

 

SY08-5

Urinary 1-OHP levels in children are modulated by cyp1a1*2c, cyp1b1*3, gstm1*0 and nqo1*2 polymorphisms
M. Sánchez-Guerra (CINVESTAV-IPN), México (Short communication) (Abstact in P107-006)